Previous data demonstrated that serum LPS, liver TLR4-mRNA, and serum inflammatory cytokines were all significantly decreased in the probiotic intervention group compared to the NAFLD model group. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.